the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Pharmaceutical Market Research

<< Previous Page:   5   6   7   8   9   10   11   12   13   14   15   16   Next >>

Reports

Iran Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
For BMI' s Q309 Iran Pharmaceutical and Healthcare Report, we expect a 9.0% compound annual growth rate (CAGR) for the total pharmaceutical market, meaning an increase in total value from US$2.27bn in 2008 to US$3.50bn by 2013. We believe the main drive ...

Israel Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMIfs updated Business Environment Rankings (BER) for Q309, Israel continued slipping down the table, now ranking seventh out of the 17 Middle East and African (MEA) markets surveyed. While the country scores strongly across the country structure an ...

IT Software Tools for Life Science and Drug Discovery R&D
Published: 2009/06 Published by: Fuji-Keizai U.S.A., Inc.
This report presents IT Software Tools for Life Science and Drug Discovery R&D. ...

Jordan Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
BMI has revised its extended forecast for Jordan' s pharmaceutical and healthcare market for our Q309 report. We expect the total drug market to grow from US$370mn in 2008 to US$519mn by 2013, representing a compound annual growth rate (CAGR) of 7.01%. ...

Kenya Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
BMI calculates Kenya' s pharmaceutical expenditure to have been KES15.85bn (US$229mn) in 2008. By 2013, we expect the total amount spent on prescription and over-the-counter (OTC) medicines to have reached a value of KES29.89bn (US$395mn) equating to a ...

Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
Table of Contents Published: 2009/06 Published by: Business Insights
The development of genomics-based molecular diagnostics that are linked to therapeutic products is critical to targeted drug developments of the future. ...

Kuwait Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Kuwaitfs pharmaceutical market is small in regional terms. Combined sales of over-the-counter (OTC) and prescription drugs reached a total of US$377mn in 2008, and we expect this to reach US$462mn by 2013 ? representing a compound annual growth rate (C ...

Latvia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
BMI calculates the Latvian pharmaceutical market to have been worth LVL256mn (US$512mn) in 2008, and by 2013, drug expenditure is expected to reach a value of LVL352mn. In US dollar terms, however, as a result of the weakening lat, drug market spending ...

Lebanon Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Lebanon remains a strong pharmaceutical market in the Middle East and Africa (MEA) region. In BMIfs updated Business Environment Ratings for Q309, Lebanon holds a respectable 13th position. The countryfs pharmaceutical market was worth US$500mn in 200 ...

Levodopa (CAS 59-92-7) Market Report 2009
Table of Contents Published: 2009/06 Published by: Merchant Research & Consulting LTD.
The study 'Levodopa (CAS 59-92-7) Market Report 2009' presents an overview of the Praduct market globally and regionally by contemplating and analyzing its parameters. ...

Liver Disease Treatments: The Global Market
Table of Contents Published: 2009/06 Published by: BCC Research
BCC' s goal in conducting this study is to provide an overview of the current and potential aspects of the global market for liver diseases treatments. The report determines the market size and market leaders, provides a market overview, and examines fact ...

Lymphoma Drug Development Strategies at Work - Define Your Competition
Table of Contents Published: 2009/06 Published by: BioSeeker Group AB
This report includes defined and up to date development strategies for 176 lymphoma therapeutic drugs (>230 projects) within the portfolio of 106 investigators, from Ceased to Marketed. In total the report assesses five different sub-indications of lympho ...

Mega-Mergers: Executing Change in the Pharma Industry
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
If consolidation is so advantageous for boosting a pharma company to a new level of productivity, why has Pfizer engaged in not just one but three mega-mergers in the past ten years: $92.3 billion for Warner-Lambert in 2000, $60 billion for Pharmacia in 2 ...

Merck KGaA: Pipeline, Products, Performance, Potential
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Merck' s pharmaceutical operations are divided into the Merck Serono business and Consumer Health Care. For the former, research and marketing efforts are centred on two key therapeutic areas, namely Oncology and Neurology. ...

Netherlands Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMI's Business Environment Rankings for Q309, the Netherlands improved its ranking from eighth, out of nine key Western European markets surveyed, to fifth. ...

New Strategies in Academic-Industry Collaborations
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
Major pharmaceutical companies are showing increased interest in directly sponsoring academic research to access innovation and fill dwindling pipelines. Recent agreements involve higher levels of collaboration and funding, are broader in scope, and focus ...

Nigeria Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMI' s Q309 update of the Pharmaceutical Business Environment Rankings for the Middle East and Africa (MEA) region, Nigeria is once again ranked second-last out of the 17 key regional markets, above only Zimbabwe. Globally, Nigeria is also ranked sec ...

North American and Western Europe Oral Solid Drug Dosage Excipients Markets
Table of Contents Published: 2009/06 Published by: Frost & Sullivan
This research service discusses trends and market metrics of the excipients market. ...

Nrt Smoking Cessation Aids in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s NRT Smoking Cessation Aids in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ...

NRT Smoking Cessation Aids in Egypt
Table of Contents Published: 2009/06 Published by: Euromonitor International
This report presents NRT Smoking Cessation Aids in Egypt. ...

Nrt Smoking Cessation Aids in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s NRT Smoking Cessation Aids in Norway report offers a comprehensive guide to the size and shape of the market at a national level. ...

NRT Smoking Cessation Aids in Saudi Arabia
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s NRT Smoking Cessation Aids in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. ...

NRT Smoking Cessation Aids in Ukraine
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s NRT Smoking Cessation Aids in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. ...

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies. The report provide ...

Opportunities in Menopausal Treatments: Will New Therapies Overtake Hormone Replacement?
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
For decades, the effi cacy of hormone replacement therapy (HRT) for some of menopause' s most troublesome symptoms eliminated any incentive to develop new approaches to treatment. However, data questioning the safety of estrogen-containing therapies have ...

OTC Healthcare - Cameroon
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s OTC Healthcare Products in Cameroon report offers a comprehensive guide to the size and shape of the market at a national level. ...

OTC Healthcare - Iran
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s OTC Healthcare Products in Iran report offers a comprehensive guide to the size and shape of the market at a national level. ...

OTC Healthcare in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
The Argentine market for OTC healthcare products saw growth during 2008, due to higher advertising expenditure aiming to make consumers aware of the benefits of products such as Elea' s Mox 12 Hs naproxen, or Boehringer' s Buscapina Fem IBS treatment. ...

OTC Healthcare in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Brand dynamics are of increasing importance, as OTC healthcare products are more widely distributed through mass retail outlets due to the recent liberalisation of distribution laws. ...

OTC Healthcare in Ukraine
Table of Contents Published: 2009/06 Published by: Euromonitor International
By the end of the review period, Ukrainian consumers continued to buy more OTC medicines due to growing levels of self-medication. ...

Pakistan Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Pakistan' s pharmaceutical expenditure was valued at PKR127bn (US$2bn) in 2008. Between 2009 and 2013, BMI forecasts that the market should grow at a nominal CAGR of 12.7% in local currency to reach PKR230bn (US$3bn) in 2013, with population growth bein ...

Pharmaceutical and healthcare market in Poland 2009
Table of Contents Published: 2009/06 Published by: PMR
The latest report from PMR - Pharmaceutical and Healthcare Market in Poland 2009 - provides information on the size of the pharmaceutical market in Poland in 2002-2008 and market size projections for 2009-2011. The main forecasts estimate the size of the ...

Pharmaceutical Pricing and Reimbursement in China
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
With a growth rate of more than 20% per year, the Chinese pharmaceutical market is set to become the third largest in the world in 2011. A radical healthcare reform package recently unveiled by the government will more than double public healthcare expend ...

Pharmacogenomics for Clinical Use and in Drug Development
Table of Contents Published: 2009/06 Published by: Trimark Publications
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ...

Pharmacogenomics: Delivering on the Promise
Table of Contents Published: 2009/06 Published by: Insight Pharma Reports
Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ...

Philippines Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
The Philippines remains ranked as the 11th most attractive pharmaceutical market among 15 major countries in the Asia Pacific region, according to BMIfs Business Environment Rankings for Q309. Nevertheless, BMI expects the country to improve this posit ...

Poland Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Poland's pharmaceutical market continues to be dominated by generic drugs, making it one of the lowest price markets in the EU. ...

Roche: Pipeline, Products, Performance, Potential
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Roche achieved strong sales results in 2007, coupled with a significant improvement in operating profitability, however, this performance could not be replicated as the company felt the effects of the global economic crisis, as well as a significant downt ...

Singapore Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMIfs Business Environment Rankings (BER) matrix for Q309, Singapore slipped from fourth to sixth position out of the 15 key countries in the Asia Pacific region, in line with worsening economic conditions and their impact on the pharmaceutical mark ...

Slovakia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Following an update to our macroeconomic variables as a result of both the eurozone accession and global economic downturn, BMI now expects Slovakiafs pharmaceutical expenditure to grow to EUR2.06bn (US$2.62bn) by 2013. While this is below our previous ...

Slovenia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMI's Business Environment Ranking table adjusted for Q309, Slovenia continued to improve its position in the Central and Eastern European (CEE) matrix and ranks 9th, up from 11th and 12th in the previous two quarters respectively. ...

SPECIAL REPORT: 2009 Chartbook of International Pharmaceutical Prices
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
Payers in all countries are increasing their pressure on manufacturers to cut prices. But prescription drug pricing and reimbursement policies vary markedly among the leading pharmaceutical markets, so, to best determine pricing, pharmaceutical companies ...

SPECIAL REPORT: Understanding Treatment Dynamics and Needs in Juvenile Idiopathic Arthritis
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
Although interviewed thought leaders acknowledge that available biological therapies have greatly improved treatment of juvenile idiopathic arthritis (JIA) - the most common rheumatic disease in children - they do not hesitate to point out unmet needs and ...

Talniflumate (CAS 66898-62-2) Market Report 2009
Table of Contents Published: 2009/06 Published by: Merchant Research & Consulting LTD.
The study 'Talniflumate (CAS 66898-62-2) Market Report 2009' presents an overview of the Praduct market globally and regionally by contemplating and analyzing its parameters. ...

Thailand Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMIfs Pharmaceutical Environment Ranking table for Q309, Thailand remains placed 10th, out of the 15 key markets surveyed in the Asia Pacific region. Thailandfs growing and ageing population and the expansion of universal healthcare coverage repres ...

The Eastern European Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
Table of Contents Published: 2009/06 Published by: Business Insights
Cardiovascular diseases and metabolic disorders are the most common groups of disease in Eastern Europe. Moreover, poor housing standards have exacerbated the spread of communicable diseases such as tuberculosis, diphtheria and cholera. In Eastern Europea ...

The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast
Table of Contents Published: 2009/06 Published by: Business Insights
The Indian Pharmaceutical Market Outlook to 2014' provides comprehensive coverage of the Indian pharmaceutical market, incorporating the market structure, pricing and regulation and detailed analyses of the leading companies and likely healthcare reforms. ...

The Pain Management Market Outlook To 2014: Competitive landscape, pipeline analysis and growth opportunities
Table of Contents Published: 2009/06 Published by: Business Insights
The global pain management market continued to demonstrate strong growth in 2007, despite patent expiries of leading products and strong generic competition. The NSAIDs segment of the market has overcome the impact of an FDA-imposed black box warning in 2 ...

The Pharmaceutical Market: Argentina
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Espicom' s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of ...

The Pharmaceutical Market: Australia
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Espicom' s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of ...


<< Previous Page:   5   6   7   8   9   10   11   12   13   14   15   16   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.